Neuropharmacology and novel drug development are at the forefront of tackling neurological and psychiatric disorders. This field focuses on understanding the interactions between drugs and the nervous system to design targeted therapies. Advances in receptor biology, neurotransmitter dynamics, and signal transduction pathways are driving innovations in drug discovery. Emerging technologies, such as high-throughput screening and in silico modeling, accelerate the identification of potential therapeutic compounds. Breakthroughs in neuropharmacology also emphasize precision medicine, tailoring treatments to individual genetic and biochemical profiles. These developments hold promise for addressing challenges in managing disorders like schizophrenia, epilepsy, and neurodegeneration effectively.
Title : Neuromodulation of scalp electroacupuncture in the treatment of autism spectrum disorder
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Title : Managing healthcare transformation towards intelligent and ethical personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Defining the genetic landscape of developmental and Epileptic encephalopathy in Egyptian children using whole exome sequencing
Hisham Megahed, The National Research Center, Egypt
Title : The action potential as a soliton: A geometric derivation from the de Broglie relation with anatomical and clinical implications
Mustafa A Khan, Sevaro Health Inc., United States
Title : Prince transform: A wave-mechanical framework for real-time EEG analysis and early Seizure prediction using chirp and drift detection
Mustafa A Khan, Sevaro Health Inc., United States
Title : Translational insights into molecular mechanisms and neurodegeneration: Bridging experimental models and clinical realities
Benjamin Adebisi Temidayo, Institute of Anatomy Cell Biology Brain and Neurodegeneration, Nigeria